pliantrx.com (PLRX) Cash per Single Share

Pliant Therapeutics, Inc. - graphic logo of issuer PLRX

The cash per share chart for Pliant Therapeutics (PLRX) demonstrates volatility driven by the fierce competition for leadership in fibrosis therapy. 2.27 shows the current value of this metric. This price action reflects a total reliance on external contractors for substance synthesis and a lack of commercial products, leaving the company dependent on investment until clinical trials are completed.

Pliant Rx (PLRX): Cash Funds per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Pliant Therapeutics, Inc. (PLRX)

- share price and expert price forecast:
- cash availability and cash flow indicators:
Summary company analysis:PLRX, Pliant Therapeutics Inc
Brand item of pliantrx.com

Cash per share measures the volume of liquid assets attributable to a single security, determining the business's intrinsic margin of safety. For Pliant Therapeutics (PLRX), this resource is critical, as the automation of drug synthesis requires constant funding for prolonged clinical trials. By analyzing the current cash per share level, an investor assesses the company's ability to cover operating expenses without additional share offerings. High liquidity minimizes bankruptcy risk during periods of market volatility. This indicator confirms the financial stability of the biopharmaceutical startup.